Yigong Powder regulates CXCL12/CXCR4 signaling to reduce glutamate release and prevent cognitive decline in mouse model of aging.
10.19540/j.cnki.cjcmm.20230811.702
- Author:
Jiang-Ping WEI
1
;
Zi-Xuan ZHAO
2
;
Jing ZENG
2
;
Fang-Hong SHANG
2
;
Lei HUA
2
;
Yong YANG
3
;
Xiao-Mei ZHANG
3
Author Information
1. the Third Level Laboratory of Traditional Chinese Medicine Chemistry of the National Administration of Traditional Chinese Medicine, Chongqing Academy of Chinese Materia Medica Chongqing 400065, China College of Pharmacy, Chongqing Medical University Chongqing 400016, China.
2. the Third Level Laboratory of Traditional Chinese Medicine Chemistry of the National Administration of Traditional Chinese Medicine, Chongqing Academy of Chinese Materia Medica Chongqing 400065, China.
3. the Third Level Laboratory of Traditional Chinese Medicine Chemistry of the National Administration of Traditional Chinese Medicine, Chongqing Academy of Chinese Materia Medica Chongqing 400065, China Luzhou Key Laboratory of Traditional Chinese Medicine for Chronic Diseases Jointly Built by Sichuan and Chongqing,the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University Luzhou 646000, China.
- Publication Type:Journal Article
- Keywords:
CXCL12/CXCR4 signaling pathway;
Yigong Powder;
aging;
cognitive decline;
glutamate
- MeSH:
Mice;
Animals;
Powders;
Receptors, Tumor Necrosis Factor, Type I;
Glutamic Acid;
Tumor Necrosis Factor-alpha/metabolism*;
Galactose/adverse effects*;
Disease Models, Animal;
Cognitive Dysfunction/prevention & control*;
Chemokines;
Drugs, Chinese Herbal
- From:
China Journal of Chinese Materia Medica
2023;48(23):6483-6491
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to explore the effect of preventive administration of Yigong Powder on the learning and memory abilities of the mouse model of aging induced by D-galactose and decipher the underlying mechanism, so as to provide a basis for the application of Yigong Powder in the prevention and treatment of cognitive decline. Forty KM mice were randomized into control, model, donepezil(1.5 mg·kg~(-1)), and high-dose(7.5 g·kg~(-1)) and low-dose(3.75 g·kg~(-1)) Yigong Powder groups. The mice in other groups except the control group were injected with D-galactose(200 g·kg~(-1)) at the back of the neck for the modeling of aging. At the same time, the mice were administrated with corresponding drugs by gavage for one month. Morris water maze was used to examine the learning and memory abilities of the mice. Hematoxylin-eosin staining was employed to observe the pathological and morphological changes of the hippocampus. The immunofluorescence assay was employed to detect the expression of ionized calcium-binding adapter molecule 1(IBA1), glial fibrillary acidic protein(GFAP), chemokine C-X-C-motif ligand 12(CXCL12), chemokine C-X-C-motif receptor 4(CXCR4) in the hippocampus and observe the positional relationship between IBA1, GFAP, and CXCR4. Western blot was employed to determine the protein levels of extracellular regulated kinase(ERK), p-ERK, and tumor necrosis factor receptor 1(TNFR1). Enzyme-linked immunosorbent assay was employed to measure the levels of glutamate and tumor necrosis factor(TNF-α) in the brain tissue and the level of TNF-α in the serum and spleen. Yigong Powder significantly shortened the escape latency, increased the times crossing platforms, and prolonged the cumulative time in quadrants of the aging mice. It alleviated the nerve cell disarrangement, increased intercellular space, and cell degeneration or death in the hippocampus and reduced the pathology score of the damaged nerve. Moreover, Yigong Powder reduced the positive area of IBA1 and GFAP, reduced the levels of TNF-α in the brain tissue, serum, and spleen, and decreased spleen index. Furthermore, Yigong Powder decreased the average fluorescence intensity of CXCL12 and CXCR4, reduced CXCR4-positive astrocytes and microglia, down-regulated the protein levels of p-ERK/ERK and TNFR1, and lowered the level of glutamate in the brain tissue. This study showed that the preventive administration of Yigong Powder can ameliorate the learning and memory decline of the D-galactose-induced aging mice by regulating the immune function of the spleen and the CXCL12/CXCR4 signaling in the brain to reduce glutamate release. However, the mechanism of Yigong San in preventing and treating dementia via regulating spleen and stomach function remains to be studied.
